Your browser doesn't support javascript.
loading
Enterococcal bacteremia in children: Clinical Significance of vancomycin resistance.
Jo, Kyo Jin; Lee, Hyeon Seo; Lee, Narae; Byun, Shin Yun; Chang, Chulhun; Park, Su Eun.
Affiliation
  • Jo KJ; Department of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Lee HS; Office for Infection control, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
  • Lee N; Department of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Byun SY; Department of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Chang C; Department of Laboratory medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Park SE; Department of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea. Electronic address: parksueun@pusan.ac.kr.
Pediatr Neonatol ; 2024 Jun 13.
Article in En | MEDLINE | ID: mdl-38972804
ABSTRACT

BACKGROUND:

We aimed to describe the clinical and microbiological characteristics of enterococcal bacteremia, as well as the effect of Enterococcus resistance against vancomycin on clinical outcomes in Korean children.

METHODS:

We retrospectively reviewed the medical records of children diagnosed with enterococci isolated from blood cultures at Pusan National University Children's Hospital between December 2009 and November 2021.

RESULTS:

In total, 64 patients were enrolled in the study. The median age was 0 years (range 0-15), and 43 (67.2%) patients were male. Enterococcus faecalis (50%) was the most commonly identified bacterial strain. Significant underlying diseases were present in 60 patients (93.8%), and the source of bacteremia was identified in 36 patients (56.3%). Among these, intravascular device was the most common identifiable source. Fifty-six (87.5%) patients had previously received broad-spectrum antibiotics and 54 (84.4%) patients were nosocomial in origin. Twenty-nine (45.3%) strains were resistant to ampicillin, and 16 (25%) strains were resistant to vancomycin. All patients with vancomycin-resistant enterococci (VRE) had underlying disease (P = 0.199), and focus of bacteremia was significantly more frequent in VRE patients (P = 0.014). Of all the patients, after appropriate antibiotic treatment, five (7.8%) patients had recurrent enterococcal bacteremia, and seven (10.9%) patients were diagnosed with bacteremia, defined as other pathogens from blood culture. The 30-day mortality rate was 7.8%.

CONCLUSION:

Enterococcal bacteremia in children is usually nosocomial and occurs in children with serious underlying diseases. Because the number of enrolled patients and mortality were small in our study, it is difficult to identify whether the factor that determines prognosis in patients with enterococcal bacteremia is VRE or an underlying disease. Further studies with a large number of patients in a specific group are needed.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pediatr Neonatol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pediatr Neonatol Year: 2024 Document type: Article